Structural polymorphism of the low-complexity C-terminal domain of TDP-43 amyloid aggregates revealed by solid-state NMR
- PMID: 37065450
- PMCID: PMC10095165
- DOI: 10.3389/fmolb.2023.1148302
Structural polymorphism of the low-complexity C-terminal domain of TDP-43 amyloid aggregates revealed by solid-state NMR
Abstract
Aberrant aggregation of the transactive response DNA-binding protein (TDP-43) is associated with several lethal neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. Cytoplasmic neuronal inclusions of TDP-43 are enriched in various fragments of the low-complexity C-terminal domain and are associated with different neurotoxicity. Here we dissect the structural basis of TDP-43 polymorphism using magic-angle spinning solid-state NMR spectroscopy in combination with electron microscopy and Fourier-transform infrared spectroscopy. We demonstrate that various low-complexity C-terminal fragments, namely TDP-13 (TDP-43300-414), TDP-11 (TDP-43300-399), and TDP-10 (TDP-43314-414), adopt distinct polymorphic structures in their amyloid fibrillar state. Our work demonstrates that the removal of less than 10% of the low-complexity sequence at N- and C-termini generates amyloid fibrils with comparable macroscopic features but different local structural arrangement. It highlights that the assembly mechanism of TDP-43, in addition to the aggregation of the hydrophobic region, is also driven by complex interactions involving low-complexity aggregation-prone segments that are a potential source of structural polymorphism.
Keywords: TDP-43; amyloid; amyotrophic lateral sclerosis; frontotemporal dementia; low-complexity domain; polymorphism; solid-state NMR.
Copyright © 2023 Shenoy, Lends, Berbon, Bilal, El Mammeri, Bertoni, Saad, Morvan, Grélard, Lecomte, Theillet, Buell, Kauffmann, Habenstein and Loquet.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Structural dissection of amyloid aggregates of TDP-43 and its C-terminal fragments TDP-35 and TDP-16.FEBS J. 2020 Jun;287(12):2449-2467. doi: 10.1111/febs.15159. Epub 2019 Dec 20. FEBS J. 2020. PMID: 31782904
-
Exploring the aggregation-prone regions from structural domains of human TDP-43.Biochim Biophys Acta Proteins Proteom. 2019 Mar;1867(3):286-296. doi: 10.1016/j.bbapap.2018.10.008. Epub 2018 Oct 11. Biochim Biophys Acta Proteins Proteom. 2019. PMID: 30315897
-
The Different Faces of the TDP-43 Low-Complexity Domain: The Formation of Liquid Droplets and Amyloid Fibrils.Int J Mol Sci. 2021 Jul 30;22(15):8213. doi: 10.3390/ijms22158213. Int J Mol Sci. 2021. PMID: 34360978 Free PMC article. Review.
-
Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils.Nat Commun. 2024 Jan 12;15(1):486. doi: 10.1038/s41467-023-44489-0. Nat Commun. 2024. PMID: 38212334 Free PMC article.
-
Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.Neural Regen Res. 2022 Jul;17(7):1423-1430. doi: 10.4103/1673-5374.330593. Neural Regen Res. 2022. PMID: 34916412 Free PMC article. Review.
Cited by
-
Expression of Wild-Type and Mutant Human TDP-43 in Yeast Inhibits TOROID (TORC1 Organized in Inhibited Domain) Formation and Autophagy Proportionally to the Levels of TDP-43 Toxicity.Int J Mol Sci. 2024 Jun 6;25(11):6258. doi: 10.3390/ijms25116258. Int J Mol Sci. 2024. PMID: 38892445 Free PMC article.
-
An adenine model of inborn metabolism errors alters TDP-43 aggregation and reduces its toxicity in yeast revealing insights into protein misfolding diseases.Microb Cell. 2025 May 22;12:119-130. doi: 10.15698/mic2025.05.850. eCollection 2025. Microb Cell. 2025. PMID: 40421380 Free PMC article.
-
Rational Design of TDP-43 Derived α-Helical Peptide Inhibitors: An In Silico Strategy to Prevent TDP-43 Aggregation in Neurodegenerative Disorders.ACS Chem Neurosci. 2024 Mar 20;15(6):1096-1109. doi: 10.1021/acschemneuro.3c00659. Epub 2024 Mar 11. ACS Chem Neurosci. 2024. PMID: 38466778 Free PMC article.
-
The Regulation of TDP-43 Structure and Phase Transitions: A Review.Protein J. 2025 Apr;44(2):113-132. doi: 10.1007/s10930-025-10261-0. Epub 2025 Feb 22. Protein J. 2025. PMID: 39987392 Review.
-
Hydrogen-Deuterium Exchange Mass Spectrometry Reveals Mechanistic Insights into RNA Oligonucleotide-Mediated Inhibition of TDP-43 Aggregation.J Am Chem Soc. 2024 Dec 11;146(49):33626-33639. doi: 10.1021/jacs.4c11229. Epub 2024 Nov 29. J Am Chem Soc. 2024. PMID: 39610319 Free PMC article.
References
LinkOut - more resources
Full Text Sources